UNSPSC 51281680: Viomycin pantothenate sulfate

This classification denotes an antitubercular agent with the molecular formula C25H43N13O10.C9H17NO5.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0JTB9X596D, chemically known as .beta.-alanine, n-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, (r)-, compd. with viomycin, sulfate (salt) (1:1:1), but more generally known as viomycin pantothenate sulfate, which bears US NIH Compound Identifier 3037980.

UNSPSC 51281680 Viomycin pantothenate sulfate is a Commodity code that in practice captures a broader range of pharmaceutical procurement activity than its narrow chemical name suggests. Recent state and local solicitations tagged to this code show demand for medical and pharmaceutical supplies spanning naloxone and drug deactivation systems, first-aid and emergency-response supplies for fire departments, and generic multi-source pharmaceuticals distributed through cooperative purchasing arrangements. The issuing bodies include county health departments (Seminole County, Florida), municipal fire and rescue services (City of Tampa), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing consortia (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). Work solicited ranges from small-quantity direct purchases of emergency-response supplies to large-scale pharmaceutical supply contracts managed through authorized wholesalers and administered across multiple participating jurisdictions.

Geographic activity concentrates in Florida, Texas, and Minnesota, with multistate cooperative arrangements reaching into Oregon and other states. Representative recent opportunities include Seminole County's IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county health building; the City of Tampa's sealed-bid procurement (26P00145, due March 13, 2026) for 169 line items of medical and first-aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000.00 and designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount; Texas HHS's RFI (HHS0017013, due April 3, 2026) seeking vendor capabilities for direct-to-manufacturer prescription fulfillment outside traditional pharmacy benefit manager arrangements; and MMCAP's RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers with a two-year contract term and evaluation weighted 75 percent on price competitiveness.